HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice: Implications in human rheumatoid arthritis

Journal of Clinical Investigation

Volumn 100, Issue 9, 1997, Pages 2227-2234

  Bradley, David S ^a   Nabozny, Gerald H ^a,d   Cheng, Shen ^a,e   Zhou, Paul ^a,f   Griffiths, Marie M ^c   Luthra, Harvinder S ^b   David, Chella S ^a,g  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^e DeKalb Poultry Research Inc   (United States)

^f NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^g MAYO GRADUATE SCHOOL   (United States)

Author keywords

Autoimmune disease; HLA class II; Rheumatoid arthritis; Transgenic mice; Type II collagen

Indexed keywords

COLLAGEN TYPE 2; HLA DQ ANTIGEN;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; DISEASE PREDISPOSITION; DISEASE SEVERITY; ETIOLOGY; FEMALE; GENETIC POLYMORPHISM; INCIDENCE; MALE; MOUSE; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TRANSGENIC MOUSE;

EID: 0030704642     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119760     Document Type: Article

References (71)

1. Goldstein, R., and F.C. Arnett. 1987. The genetics of rheumatic disease in man. Rheum. Dis. Clin. N. Am. 13:487-510.
2. Nepom, G.T. 1989. Determinants of genetic susceptibility in HLA-associated autoimmune disease. Clin. Immunol. Immunopathol. 53(2 Pt 2):S53-S62.
3. Torfs, C.P., M.C. King, B. Huey, J. Malmgren, and F.C. Grumet. 1986. Genetic interrelationship between insulin-dependent diabetes mellitus, the autoimmune thyroid diseases, and rheumatoid arthritis. Am. J. Hum. Genet. 38: 170-187.
4. Chaplin, D.D., and M.E. Kemp. 1988. The major histocompatibility complex and autoimmunity. Year. Immunol. 3:179-198.
5. Badenhoop, K. 1990. Immunogenetic markers for autoimmune diseases of the endocrine system. Klin. Wochenschr. 68(Suppl. 21):10-14.
6. Skanes, V.M., J. Barnard, N. Farid, W.H. Marshall, L. Murphy, D. Rideout, R. Taylor, G. Xidos, and B. Larsen. 1986. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis. Mol. Biol. Med. 3:143-157.
7. Farid, N.R., and C. Thompson. 1986. HLA and autoimmune endocrine disease 1985. Mol. Biol. Med. 3:85-97.
8. Arnett, F.C., and J.D. Reveille. 1992. Genetics of systemic lupus erythematosus. Rheum. Dis. Clin. North Am. 18:865-892.
9. Christiansen, F.T., W.J. Zhang, M. Griffiths, S.A. Mallal, and R.L. Dawkins. 1991. Major histocompatibility complex (MHC) complement deficiency, ancestral haplotypes and systemic lupus erythematosus (SLE): C4 deficiency explains some but not all of the influence of the MHC. J. Rheumatol. 18:1350-1358.
10. Skarsvag, S., K.E. Hansen, A. Holst, and T. Moen. 1992. Distribution of HLA class II alleles among Scandinavian patients with systemic lupus erythematosus (SLE): an increased risk of SLE among non[DRB1*03,DQA1*0501, DQB1*0201] class II homozygotes? Tissue Antigens. 40:128-133.
11. Arnett, F.C., W.B. Bias, and J.D. Reveille. 1989. Genetic studies in Sjogren's syndrome and systemic lupus erythematosus. J. Autoimmun. 2:403-413.
12. Oksenberg, J.R., A.B. Begovich, H.A. Erlich, and L. Steinman. 1993. Genetic factors in multiple sclerosis. JAMA. 270:2362-2369.
13. Maclaren, N.K., and W.J. Riley. 1986. Inherited susceptibility to autoimmune Addison's disease is linked to human leukocyte antigens-DR3 and/or DR4, except when associated with type I autoimmune polyglandular syndrome. J. Clin. Endocrinol. Metab. 62:455-159.
14. Wilson, C., A. Ebringer, K. Ahmadi, J. Wrigglesworth, H. Tiwana, M. Fielder, A. Binder, C. Ettelaie, P. Cunningham, C. Joannou, and S. Bansal. 1995. Shared amino acid sequences between major histocompatibility complex class II glycoproteins, type XI collagen and Proteus mirabilis in rheumatoid arthritis. Ann. Rheum. Dis. 54:216-220.
15. Zanelli, E., C.J. Krco, J.M. Baisch, S. Cheng, and C.S. David. 1996. Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis. Proc. Natl. Acad. Sci. USA. 93:1814-1819.
16. Vogt, A.B., H. Kropshofer, H. Kalbacher, M. Kalbus, H.G. Rammensee, J.E. Coligan, and R. Martin. 1994. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides. J. Immunol. 153: 1665-1673.
17. Chicz, R.M., W.S. Lane, R.A. Robinson, M. Trucco, J.L. Strominger, and J.C. Gorga. 1994. Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8. Int. Immunol. 6:1639-1649.
18. Nepom, G.T., and H. Erlich. 1991. MHC class-II molecules and autoimmunity. Annu. Rev. Immunol. 9:493-525.
19. Wordsworth, B.P., J.S. Lanchbury, L.I. Sakkas, K.I. Welsh, G.S. Panayi, and J.I. Bell. 1989. HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc. Natl. Acad. Sci. USA. 86:10049-10053.
20. Ollier, W., and W. Thomson. 1992. Population genetics of rheumatoid arthritis. Rheum. Dis. Clin. North Am. 18:741-759.
21. Gregersen, P.K., M. Shen, Q.L. Song, P. Merryman, S. Degar, T. Seki, J. Maccari, D. Goldberg, H. Murphy, J. Schwenzer, et al. 1986. Molecular diversity of HLA-DR4 haplotypes. Proc. Natl. Acad. Sci. USA. 83:2642-2646.
22. Gregersen, P.K., J. Silver, and R.J. Winchester. 1987. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30:1205-1209.
23. Winchester, R., E. Dwyer, and S. Rose. 1992. The genetic basis of rheumatoid arthritis. The shared epitope hypothesis. Rheum. Dis. Clin. North Am. 18:761-783.
24. Willkens, R.F., G.T. Nepom, C.R. Marks, J.W. Nettles, and B.S. Nepom. 1991. Association of HLA-Dw16 with rheumatoid arthritis in Yakima Indians. Further evidence for the "shared epitope" hypothesis. Arthritis Rheum. 34:43-47.
25. Yelamos, J., J.R. Garcia-Lozano, I. Moreno, I. Aguilera, M.F. Gonzalez, A. Garcia, A. Nunez-Roldan, and B. Sanchez. 1993. Association of HLA-DR4-Dw15 (DRB1*0405) and DR10 with rheumatoid arthritis in a Spanish population. Arthritis Rheum. 36:811-814.
26. Sattar, M.A., M. al-Saffar, R.T. Guindi, T.N. Sugathan, and K. Behbehani. 1990. Association between HLA-DR antigens and rheumatoid arthritis in Arabs. Ann. Rheum. Dis. 49:147-149.
27. Begovich, A.B., G.R. McClure, V.C. Suraj, R.C. Helmuth, N. Fildes, T.L. Bugawan, H.A. Erlich, and W. Klitz. 1992. Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. J. Immunol. 148: 249-258.
28. Harley, J.B., M. Reichlin, F.C. Arnett, E.L. Alexander, W.B. Bias, and T.T. Provost. 1986. Gene interaction at HLA-DQ enhances autoantibody production in primary Sjogren's syndrome. Science (Wash. DC). 232:1145-1147.
29. Bell, J., L. Rassenti, S. Smoot, K. Smith, C. Newby, R. Hohlfeld, K. Toyka, H. McDevitt, and L. Steinman. 1986. HLA-DQ beta-chain polymorphism linked to myasthenia gravis. Lancet. 1:1058-1060.
30. Todd, J.A., J.I. Bell, and H.O. McDevitt. 1987. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature (Lond.). 329:599-604.
31. Baisch, J.M., T. Weeks, R. Giles, M. Hoover, P. Stastny, and J.D. Capra. 1990. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N. Eng. J. Med. 322:1836-1841.
32. Singal, D.P., M. D'Souza, B. Reid, W.G. Bensen, Y.B. Kassam, and J.D. Adachi. 1987. HLA-DQ beta-chain polymorphism in HLA-DR4 haplotypes associated with rheumatoid arthritis. Lancet. 2:1118-1120.
33. Lanchbury, J.S., L.I. Sakkas, S.G. Marsh, J.G. Bodmer, K.I. Welsh, and G.S. Panayi. 1989. HLA-DQ beta 3.1 allele is a determinant of susceptibility to DR4-associated rheumatoid arthritis. Hum. Immunol. 26:59-71.
34. Taneja, V., N.K. Mehra, A.N. Chandershekaran, R.K. Ahuja, Y.N. Singh, and A.N. Malaviya. 1992. HLA-DR4-DQw8, but not DR4-DQw7 haplotypes, occur in Indian patients with rheumatoid arthritis. Rheumatol. Int. 11: 251-255.
35. Stuart, J.M., A.S. Townes, and A.H. Kang. 1984. Collagen autoimmune arthritis. Annu. Rev. Immunol. 2:199-218.
36. Stuart, J.M., E.H. Huffstutter, A.S. Townes, and A.H. Kang. 1983. Incidence and specificity of antibodies to types I, II, III, IV, and V collagen in rheumatoid arthritis and other rheumatic diseases as measures by 125I-radioimmunoassay. Arthritis Rheum. 26:832-840.
37. Trentham, D.E. 1982. Collagen arthritis as a relevant model for rheumatoid arthritis. Arthritis Rheum. 25:911-916.
38. Trentham, D.E., G.M. Kammer, W.J. McCune, and J.R. David. 1981. Autoimmunity to collagen: a shared feature of psoriatic and rheumatoid arthritis. Arthritis Rheum. 24:1363-1369.
39. Trentham, D.E., A.S. Townes, and A.H. Kang. 1977. Autoimmunity to type II collagen: an experimental model of arthritis. J. Exp. Med. 146:857-868.
40. Yoo, T.J., S.Y. Kim, J.M. Stuart, R.A. Floyd, G.A. Olson, M.A. Cremer, and A.H. Kang. 1988. Induction of arthritis in monkeys by immunization with type II collagen. J. Exp. Med. 168:777-782.
41. Wooley, P.H., H.S. Luthra, J.M. Stuart, and C.S. David. 1981. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J. Exp. Med. 154:688-700.
42. Nabozny, G.H., J.M. Baisch, S. Cheng, D. Cosgrove, M.M. Griffiths, H.S. Luthra, and C.S. David. 1996. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J. Exp. Med. 183:27-37.
43. Wei, B.Y., J. Martin, S. Savarirayan, R. Little, and C.S. David. 1990. Transgenic mice and mutants in MHC research. I.K. Egorov and C.S. David, editors. Springer-Verlag, Berlin, Heidelberg, Germany. 237-246.
44. Okada, K., J.M. Boss, H. Prentice, T. Spies, R. Mengler, C. Auffray, J. Lillie, D. Grossberger, and J.L. Strominger. 1985. Gene organization of DC and DX subregions of the human major histocompatibility complex. Proc. Natl. Acad. Sci. USA. 82:3410-3414.
45. Zhou, P., G.D. Anderson, S. Savarirayan, H. Inoko, and C.S. David. 1991. Thymic deletion of V beta 11+, V beta 5+ T cells in H-2E negative. HLA-DQ beta+ single transgenic mice. J. Immunol. 146:854-859.
46. Cosgrove, D., D. Gray, A. Dierich, J. Kaufman, M. Lemeur, C. Benoist, and D. Mathis. 1991. Mice lacking MHC class II molecules. Cell. 66:1051-1066.
47. Giles, R.C., G. Nunez, C.K. Hurley, A. Nunez-Roldan, R. Winchester, P. Stastny, and J.D. Capra. 1983. Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB3-like specificity. J. Exp. Med. 157:1461-1470.
48. Lampson, L.A., and R. Levy. 1980. Two populations of Ia-like molecules on a human B cell line. J. Immunol. 125:293-299.
49. Beck, B.N., J.M. Buerstedde, C.J. Krco, A.E. Nilson, C.G. Chase, and D.J. McKean. 1986. Characterization of cell lines expressing mutant I-Ab and I-Ak molecules allows the definition of distinct serologic epitopes on A alpha and A beta polypeptides. J. Immunol. 136:2953-2961.
50. Lerner, E.A., L.A. Matis, C.A. Janeway, Jr., P.P. Jones, R.H. Schwartz, and D.B. Murphy. 1980. Monoclonal antibody against an Ir gene product? J. Exp. Med. 152:1085-1101.
51. Gregoire, C., N. Rebai, F. Schweisguth, A. Necker, G. Mazza, N. Auphan, A. Millward, A.M. Schmitt-Verhulst, and B. Malissen. 1991. Engineered secreted T-cell receptor alpha beta heterodimers. Proc. Natl. Acad. Sci. USA. 88:8077-8081.
52. Tomonari, K., E. Lovering, and S. Spencer. 1990. Correlation between the V beta 4+ CD8+ T-cell population and the H-2d haplotype. Immunogenetics. 31:333-339.
53. Kanagawa, O., Y. Utsunomiya, J. Bill, E. Palmer, M.W. Moore, and F.R. Carbone. 1991. Conformational difference of T cell antigen receptors revealed by monoclonal antibodies to mouse V beta 5 T cell receptor for antigen determinants. J. Immunol. 147:1307-1314.
54. Acha-Orbea, H., R.M. Zinkernagel, and H. Hengartner. 1985. Cytotoxic T cell clone-specific monoclonal antibodies used to select clonotypic antigen-specific cytotoxic T cells. Eur. J. Immunol. 15:31-36.
55. Okada, C.Y., B. Holzmann, C. Guidos, E. Palmer, and I.L. Weissman. 1990. Characterization of a rat monoclonal antibody specific for a determinant encoded by the V beta 7 gene segment. Depletion of V beta 7+ T cells in mice with Mls-1a haplotype. J. Immunol. 144:3473-3477.
56. Staerz, U.D., H.G. Rammensee, J.D. Benedetto, and M.J. Bevan. 1985. Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor. J. Immunol. 134:3994-4000.
57. Haskins, K., C. Hannum, J. White, N. Roehm, R. Kubo, J. Kappler, and P. Marrack. 1984. The antigen-specific, major histocompatibility complex-restricted receptor on T cells. VI. An antibody to a receptor allotype. J. Exp. Med. 160:452-171.
58. Kappler, J.W., U. Staerz, J. White, and P.C. Marrack. 1988. Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex. Nature (Lond.). 332:35-40.
59. Bill, J., O. Kanagawa, D.L. Woodland, and E. Palmer. 1989. The MHC molecule I-E is necessary but not sufficient for the clonal deletion of V beta 11-bearing T cells. J. Exp. Med. 169:1405-1419.
60. Liao, N.S., J. Maltzman, and D.H. Raulet. 1989. Positive selection determines T cell receptor V beta 14 gene usage by CD8+ T cells. J. Exp. Med. 170: 135-143.
61. Kappler, J.W., N. Roehm, and P. Marrack. 1987. T cell tolerance by clonal elimination in the thymus. Cell. 49:273-280.
62. Griffiths, M.M., E.J. Eichwald, J.H. Martin, C.B. Smith, and C.W. DeWitt. 1981. Immunogenetic control of experimental type II collage induced arthritis. Arthritis Rheum. 24:781-789.
63. Griffiths, M.M., G.H. Nabozny, J. Hanson, D.S Harper, S. McCall, K.G. Moder, G.W. Cannon, H.S. Luthra, and C.S. David. 1994. Collagen-induced arthritis and TCRs in SWR and B10.Q mice expressing an Ek alpha transgene. J. Immunol. 153:2758-2768.
64. Krco, C.J., S. Chapoval. J. Harders, T. Neeno, and C.S. David. 1996. Identification of HLA-DQ restricted T cell epitopes on dust mite, grass, and weed allergens using HLA-DQ6 transgenic mice. Hum. Immunol. 49:16. (Abstr.)
65. DeSouza, N.F., E. Zanelli, B. Wilson, J.L. Strominger, S.R. Munn, and C.S. David. 1996. Definition of antigenic determinants on glutamic acid decarboxylase molecule in HLA-DQ transgenic mice. Hum. Immunol. 47:151. (Abstr.)
66. Gonzalez-Gay, M.A., E. Zanelli, S.D. Khare, C.J. Krco, P. Zhou, M.M. Griffiths, H.S. Luthra, and C.S. David. 1996. Human leukocyte antigen-DRB1*1502 (DR2Dw12) transgene reduces incidence and severity of arthritis in mice. Hum. Immunol. 50:54-60.
67. Deighton, C.M., G. Cavanagh, A.S. Rigby, H.L. Lloyd, and D.J. Walker. 1993. Both inherited HLA-haplotypes are important in the predisposition to rheumatoid arthritis. Br. J. Rheumatol. 32:893-898.
68. Wordsworth, P., K.D. Pile, J.D. Buckely, J.S. Lanchbury, B. Oilier, M. Lathrop, and J.I. Bell. 1992. HLA heterozygosity contributes to susceptibility to rheumatoid arthritis. Am. J. Hum. Genet. 51:585-591.
69. Weyand, C.M., K.C. Hicok, D.L. Conn, and J.J. Goronzy. 1992. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann. Intern. Med. 117:801-806.
70. Zanelli, E., C.J. Krco, and C.S. David. 1997. Critical residues on HLA-DRB1*0402 HV3 peptide for HLA-DQ8-restricted immunogenicity: implications for rheumatoid arthritis predisposition. J. Immunol. 158:3545-3551.
71. Auger, I., and J. Roudier. 1997. A function for the QKRAA amino acid motif: mediating binding of DNAJ to DNAK. Implications for the association of rheumatoid arthritis with HLA-DR4. J. Clin. Invest. 9:1818-1822.